YAP in development and disease: Navigating the regulatory landscape from retina to brain - 29/05/24
, Kai Yao a, b, 2, ⁎ 
Abstract |
The distinctive role of Yes-associated protein (YAP) in the nervous system has attracted widespread attention. This comprehensive review strategically uses the retina as a vantage point, embarking on an extensive exploration of YAP’s multifaceted impact from the retina to the brain in development and pathology. Initially, we explore the crucial roles of YAP in embryonic and cerebral development. Our focus then shifts to retinal development, examining in detail YAP’s regulatory influence on the development of retinal pigment epithelium (RPE) and retinal progenitor cells (RPCs), and its significant effects on the hierarchical structure and functionality of the retina. We also investigate the essential contributions of YAP in maintaining retinal homeostasis, highlighting its precise regulation of retinal cell proliferation and survival. In terms of retinal-related diseases, we explore the epigenetic connections and pathophysiological regulation of YAP in diabetic retinopathy (DR), glaucoma, and proliferative vitreoretinopathy (PVR). Lastly, we broaden our exploration from the retina to the brain, emphasizing the research paradigm of “retina: a window to the brain.” Special focus is given to the emerging studies on YAP in brain disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), underlining its potential therapeutic value in neurodegenerative disorders and neuroinflammation.
Le texte complet de cet article est disponible en PDF.Highlights |
• | YAP plays a crucial role in brain and retinal development. |
• | YAP regulates retinal homeostasis and triggers reprogramming in Müller cells. |
• | YAP contributes significantly to the pathogenesis of diabetic retinopathy, glaucoma, and proliferative vitreoretinopathy. |
• | YAP is implicated in the progression of neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. |
Keywords : YAP, Hippo signaling pathway, Retina development, Retinal diseases, Brain-related diseases
Plan
Vol 175
Article 116703- juin 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
